Literature DB >> 18713839

S-adenosylhomocysteine hydrolase downregulation contributes to tumorigenesis.

J F Leal1, I Ferrer, C Blanco-Aparicio, J Hernández-Losa, S Ramón Y Cajal, A Carnero, M E Lleonart.   

Abstract

With the idea to discover novel genes involved in proliferation, we have performed a genome-wide loss-of-function genetic screen to identify additional putative tumor suppressor genes. We have previously identified five genes belonging to different biochemical families. In this report, we focused on the study of one of these genes designated S-adenosylhomocysteine hydrolase (SAHH), which has also been previously identified in an independent short hairpin RNA screening. SAHH inactivation confers resistance to both p53 and p16(INK4)-induced proliferation arrest. Interestingly, SAHH inactivation inhibits p53 transcriptional activity and impairs DNA damage-induced transcription of p21(Cip1). Given that SAHH downregulation modulates senescence in primary cells, we also studied SAHH expression in human tumors at the messenger RNA (mRNA) and protein levels. SAHH mRNA was lost in 50% of tumor tissues from 206 patients with different kinds of tumors in comparison with normal tissue counterparts. Moreover, SAHH protein was also affected in some colon cancers. Such findings may be of relevance to cancer research, suggesting that SAHH might be a largely unexplored tumor suppressor.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18713839     DOI: 10.1093/carcin/bgn198

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  31 in total

Review 1.  Bypassing cellular senescence by genetic screening tools.

Authors:  Mar Vergel; Amancio Carnero
Journal:  Clin Transl Oncol       Date:  2010-06       Impact factor: 3.405

2.  Mice deficient in cystathionine beta synthase display increased Dyrk1A and SAHH activities in brain.

Authors:  Chris Planque; Julien Dairou; Christophe Noll; Linh-Chi Bui; Clémentine Ripoll; Fayçal Guedj; Jean-Maurice Delabar; Nathalie Janel
Journal:  J Mol Neurosci       Date:  2012-06-15       Impact factor: 3.444

3.  Overexpression of S-adenosylhomocysteine hydrolase (SAHH) in esophageal squamous cell carcinoma (ESCC) cell lines: effects on apoptosis, migration and adhesion of cells.

Authors:  Qinghua Li; Lihong Mao; Ruili Wang; Liqiang Zhu; Lexun Xue
Journal:  Mol Biol Rep       Date:  2014-01-16       Impact factor: 2.316

4.  S-adenosyl homocysteine hydrolase (SAHH) accelerates flagellar regeneration in Dunaliella salina.

Authors:  Qinghua Li; Liqiang Zhu; Yunmeng Yan; Dandan Chai; Jie Li; Lexun Xue
Journal:  Curr Microbiol       Date:  2013-03-27       Impact factor: 2.188

Review 5.  How to become immortal: let MEFs count the ways.

Authors:  Adam Odell; Jon Askham; Catherine Whibley; Monica Hollstein
Journal:  Aging (Albany NY)       Date:  2010-03-31       Impact factor: 5.682

6.  Conserved sequence repeats of IQGAP1 mediate binding to Ezrin.

Authors:  Jing Liu; Jesse J Guidry; David K Worthylake
Journal:  J Proteome Res       Date:  2013-12-17       Impact factor: 4.466

7.  Differential patterns of liver proteins in experimental murine hepatosplenic schistosomiasis.

Authors:  B Manivannan; P Rawson; T W Jordan; W E Secor; A C La Flamme
Journal:  Infect Immun       Date:  2009-11-23       Impact factor: 3.441

8.  Regulation of S-adenosylhomocysteine hydrolase by lysine acetylation.

Authors:  Yun Wang; Jennifer M Kavran; Zan Chen; Kannan R Karukurichi; Daniel J Leahy; Philip A Cole
Journal:  J Biol Chem       Date:  2014-09-23       Impact factor: 5.157

9.  Adult-onset liver disease and hepatocellular carcinoma in S-adenosylhomocysteine hydrolase deficiency.

Authors:  Stefan Stender; Rima S Chakrabarti; Chao Xing; Garrett Gotway; Jonathan C Cohen; Helen H Hobbs
Journal:  Mol Genet Metab       Date:  2015-10-26       Impact factor: 4.797

Review 10.  Senescence induction; a possible cancer therapy.

Authors:  Matilde E Lleonart; Ana Artero-Castro; Hiroshi Kondoh
Journal:  Mol Cancer       Date:  2009-01-08       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.